Emanuel Raschi

Institutionuniversity of Bologna
AddressBologna
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in July 2020 and August 2020 and December 2020 and January 2021 and July 2021
    All Publications
    Bar chart showing 69 publications over 14 distinct years, with a maximum of 13 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gatti M, Turrini E, Raschi E, Sestili P, Fimognari C. Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. Pharmaceuticals (Basel). 2021 Jul 28; 14(8). PMID: 34451835.
      Citations: 6     
    2. Gatti M, Raschi E, Moretti U, Ardizzoni A, Poluzzi E, Diemberger I. Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel). 2021 Jan 04; 9(1). PMID: 33406694.
      Citations: 3     
    3. Gatti M, Raschi E, Poluzzi E, Martignani C, Salvagni S, Ardizzoni A, Diemberger I. The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia. Curr Heart Fail Rep. 2020 12; 17(6):365-383. PMID: 33025463.
      Citations: 4     Fields:    Translation:Humans
    4. Raschi E, Caraceni P, Poluzzi E, De Ponti F. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? Expert Opin Drug Saf. 2020 10; 19(10):1367-1369. PMID: 32840116.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    5. Gatti M, Fusaroli M, Caraceni P, Poluzzi E, De Ponti F, Raschi E. Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19. Br J Clin Pharmacol. 2021 03; 87(3):1533-1540. PMID: 32639062.
      Citations: 9     Fields:    Translation:Humans
    6. Fadini GP, Sarangdhar M, De Ponti F, Avogaro A, Raschi E. Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2019; 7(1):e000725. PMID: 31641524.
      Citations: 6     Translation:Humans
    7. Raschi E, Antonazzo IC, Poluzzi E, De Ponti F. Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list? Ann Rheum Dis. 2021 07; 80(7):e120. PMID: 31189551.
      Citations: 4     Fields:    Translation:Humans
    8. Raschi E, Poluzzi E, Marchesini G, De Ponti F. Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? Expert Opin Pharmacother. 2019 Jun; 20(9):1087-1090. PMID: 30920851.
      Citations:    Fields:    Translation:Humans
    9. Raschi E, Mazzotti A, Poluzzi E, De Ponti F, Marchesini G. Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease. Expert Opin Pharmacother. 2018 12; 19(17):1903-1914. PMID: 30299993.
      Citations: 2     Fields:    Translation:Humans
    10. Mei R, Raschi E, Forcesi E, Diemberger I, De Ponti F, Poluzzi E. Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System. Int J Cardiol. 2018 Dec 15; 273:183-186. PMID: 30236504.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    11. Raschi E, Poluzzi E, Fadini GP, Marchesini G, De Ponti F. Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough? Diabetes Obes Metab. 2018 12; 20(12):2711-2723. PMID: 30003655.
      Citations: 8     Fields:    Translation:Humans
    12. Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E, De Ponti F, Poluzzi E. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System. Expert Opin Drug Saf. 2018 Sep; 17(9):869-874. PMID: 30058390.
      Citations: 2     Fields:    Translation:Humans
    13. Raschi E, Diemberger I, Poluzzi E, De Ponti F. Reporting of immune checkpoint inhibitor-associated myocarditis. Lancet. 2018 08 04; 392(10145):383. PMID: 30102168.
      Citations: 3     Fields:    Translation:Humans
    14. Raschi E, Girardi A, Poluzzi E, Forcesi E, Menniti-Ippolito F, Mazzanti G, De Ponti F. Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems. Drug Saf. 2018 08; 41(8):745-752. PMID: 29582393.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    15. Raschi E, Fertonani Affini L, Antonazzo IC, Diemberger I, Poluzzi E, De Ponti F. Drug-induced Kounis syndrome: A matter of pharmacovigilance. Int J Cardiol. 2019 01 01; 274:381. PMID: 30057169.
      Citations: 2     Fields:    Translation:Humans
    16. Mei R, Raschi E, Poluzzi E, Diemberger I, De Ponti F. Recurrence of pericarditis after influenza vaccination: a case report and review of the literature. BMC Pharmacol Toxicol. 2018 05 05; 19(1):20. PMID: 29728118.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    17. Raschi E, Diemberger I, Cosmi B, De Ponti F. ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply. Intern Emerg Med. 2018 06; 13(4):635-636. PMID: 29696520.
      Citations: 4     Fields:    Translation:Humans
    18. Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res. 2018 06; 132:108-118. PMID: 29665426.
      Citations: 8     Fields:    Translation:Humans
    19. Carnovale C, Raschi E, Leonardi L, Moretti U, De Ponti F, Gentili M, Pozzi M, Clementi E, Poluzzi E, Radice S. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase. Expert Rev Vaccines. 2018 04; 17(4):363-381. PMID: 29452497.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    20. Dothel G, Barbaro MR, Raschi E, Barbara G, De Ponti F. Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert Opin Investig Drugs. 2018 03; 27(3):251-263. PMID: 29451407.
      Citations: 2     Fields:    Translation:HumansAnimals
    21. Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B. Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis. Vaccine. 2018 03 14; 36(12):1548-1555. PMID: 29454521.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    22. Raschi E, De Ponti F. Liver injury with direct-acting anticoagulants: has the fog cleared? Heart. 2017 12; 103(24):2010. PMID: 29180521.
      Citations:    Fields:    Translation:Humans
    23. Diemberger I, Raschi E, Trifirò G. Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies. Clin Drug Investig. 2017 10; 37(10):985-988. PMID: 28831689.
      Citations: 2     Fields:    Translation:Humans
    24. Raschi E, Diemberger I, Cosmi B, De Ponti F. ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations. Intern Emerg Med. 2018 01; 13(1):1-9. PMID: 28942550.
      Citations: 10     Fields:    Translation:Humans
    25. Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D'Alessandro R, De Ponti F, Poluzzi E. Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping. Drug Saf. 2017 09; 40(9):823-834. PMID: 28597251.
      Citations: 1     Fields:    Translation:Humans
    26. Raschi E, Bianchin M, Fantoni C, Ageno W, De Ponti F, De Ponti R. Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Intern Emerg Med. 2017 Oct; 12(7):923-934. PMID: 28785902.
      Citations: 4     Fields:    Translation:Humans
    27. Poluzzi E, Raschi E, Diemberger I, De Ponti F. Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice. Drug Saf. 2017 06; 40(6):461-464. PMID: 28389980.
      Citations: 5     Fields:    Translation:Humans
    28. Raschi E, Bianchin M, De Ponti R, De Ponti F, Ageno W. Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective. Pharmacol Res. 2017 Jun; 120:206-218. PMID: 28366835.
      Citations: 3     Fields:    Translation:HumansAnimals
    29. Girardi A, Raschi E, Galletti S, Allegaert K, Poluzzi E, De Ponti F. Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development. Expert Opin Drug Metab Toxicol. 2017 May; 13(5):555-565. PMID: 28141945.
      Citations: 1     Fields:    Translation:HumansAnimals
    30. Raschi E, De Ponti F. Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol. 2017 Jan 08; 9(1):30-37. PMID: 28105256.
      Citations: 9     
    31. Hazell L, Raschi E, De Ponti F, Thomas SH, Salvo F, Ahlberg Helgee E, Boyer S, Sturkenboom M, Shakir S. Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project. J Clin Pharmacol. 2017 05; 57(5):558-572. PMID: 28019033.
      Citations: 2     Fields:    Translation:HumansAnimals
    32. Raschi E, Bianchin M, Ageno W, De Ponti R, De Ponti F. Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. Drug Saf. 2016 12; 39(12):1175-1187. PMID: 27696300.
      Citations: 8     Fields:    Translation:Humans
    33. Dothel G, Raschi E, Rimondini R, De Ponti F. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology. World J Gastroenterol. 2016 Nov 07; 22(41):9057-9068. PMID: 27895395.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    34. Raschi E, Bianchin M, Ageno W, De Ponti R, De Ponti F. Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications. Pol Arch Med Wewn. 2016 Aug 25; 126(7-8):552-61. PMID: 27578223.
      Citations: 9     Fields:    Translation:Humans
    35. Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, Bégaud B, Pariente A. Authors' reply to Tufan and colleagues and Boucaud-Maitre. BMJ. 2016 Jun 07; 353:i3188. PMID: 27267359.
      Citations:    Fields:    Translation:Humans
    36. Raschi E, Salvo F, Poluzzi E, De Ponti F. Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting Systems. J Am Coll Cardiol. 2016 05 10; 67(18):2193. PMID: 27151356.
      Citations: 1     Fields:    
    37. Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, Bégaud B, Pariente A. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. BMJ. 2016 05 03; 353:i2231. PMID: 27142267.
      Citations: 24     Fields:    Translation:Humans
    38. Raschi E, Poluzzi E, De Ponti F. Stroke, Migraine and Triptans: From Bedside to Bench. EBioMedicine. 2016 04; 6:14-15. PMID: 27211537.
      Citations: 1     Fields:    Translation:Humans
    39. Raschi E, Poluzzi E, Salvo F, Moretti U, De Ponti F. Authors' Reply to Alain Braillon's Comment on "The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project". Drug Saf. 2016 Apr; 39(4):367-8. PMID: 26895342.
      Citations:    Fields:    Translation:Humans
    40. Lodato F, Poluzzi E, Raschi E, Piccinni C, Koci A, Olivelli V, Napoli C, Corvalli G, Nalon E, De Ponti F, Zoli M. Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy. Eur J Intern Med. 2016 May; 30:31-36. PMID: 26926561.
      Citations: 5     Fields:    Translation:Humans
    41. Raschi E, Poluzzi E, Salvo F, Koci A, Suling M, Antoniazzi S, Perina L, Hazell L, Moretti U, Sturkenboom M, Garbe E, Pariente A, De Ponti F. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. Drug Saf. 2016 Jan; 39(1):59-68. PMID: 26446144.
      Citations: 9     Fields:    Translation:Humans
    42. Poluzzi E, Veronese G, Piccinni C, Raschi E, Koci A, Pagano P, Godman B, Marchesini G, Boriani G, De Ponti F. Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy. Basic Clin Pharmacol Toxicol. 2016 Jan; 118(1):63-9. PMID: 26150075.
      Citations: 1     Fields:    Translation:Humans
    43. Raschi E, De Ponti F. Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World J Hepatol. 2015 Jul 08; 7(13):1761-71. PMID: 26167249.
      Citations: 16     
    44. Raschi E, Poluzzi E, Koci A, Salvo F, Pariente A, Biselli M, Moretti U, Moore N, De Ponti F. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system. Br J Clin Pharmacol. 2015 Aug; 80(2):285-93. PMID: 25689417.
      Citations: 21     Fields:    Translation:Humans
    45. Raschi E, Poluzzi E, De Ponti F. Comment on: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus". Clin Pharmacokinet. 2015 Apr; 54(4):447-8. PMID: 25721222.
      Citations: 3     Fields:    Translation:Humans
    46. Raschi E, Poluzzi E, Koci A, Caraceni P, Ponti FD. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database. World J Hepatol. 2014 Aug 27; 6(8):601-12. PMID: 25232453.
      Citations: 20     
    47. Girardi A, Piccinni C, Raschi E, Koci A, Vitamia B, Poluzzi E, De Ponti F. Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey. BMC Complement Altern Med. 2014 Jul 23; 14:262. PMID: 25055888.
      Citations: 2     Fields:    Translation:Humans
    48. Godman B, Petzold M, Bennett K, Bennie M, Bucsics A, Finlayson AE, Martin A, Persson M, Piessnegger J, Raschi E, Simoens S, Zara C, Barbui C. Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications. BMC Med. 2014 Jun 13; 12:98. PMID: 24927744.
      Citations: 13     Fields:    Translation:Humans
    49. Salvo F, Raschi E, Moretti U, Chiarolanza A, Fourrier-Réglat A, Moore N, Sturkemboom M, De Ponti F, Poluzzi E, Pariente A. Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation. Eur J Clin Pharmacol. 2014 May; 70(5):617-25. PMID: 24595599.
      Citations: 4     Fields:    Translation:Humans
    50. Raschi E, De Ponti F. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opin Drug Metab Toxicol. 2014 Feb; 10(2):293-305. PMID: 24387275.
      Citations: 2     Fields:    Translation:HumansAnimals
    51. Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014; 21(4):417-36. PMID: 24164197.
      Citations: 28     Fields:    Translation:Humans
    52. Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M, Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One. 2013; 8(11):e81208. PMID: 24278396.
      Citations: 19     Fields:    Translation:Humans
    53. Godman B, De Bruyn K, Miranda J, Raschi E, Bennie M, Barbui C, Simoens S. Generic atypical antipsychotic drugs in Belgium: their influence and implications. J Comp Eff Res. 2013 Nov; 2(6):551-61. PMID: 24236794.
      Citations: 7     Fields:    Translation:Humans
    54. Raschi E, Piccinni C, Marchesini G. Glucagon-like peptide 1-based drugs and pancreatic safety. JAMA Intern Med. 2013 Oct 28; 173(19):1843. PMID: 24165845.
      Citations:    Fields:    Translation:Humans
    55. Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, Sturkenboom M, De Ponti F. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf. 2013 Jun; 36(6):467-79. PMID: 23553446.
      Citations: 30     Fields:    Translation:Humans
    56. Godman B, Bucsics A, Burkhardt T, Piessnegger J, Schmitzer M, Barbui C, Raschi E, Bennie M, Gustafsson LL. Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future. Front Pharmacol. 2012; 3:198. PMID: 23308071.
      Citations: 6     
    57. Piccinni C, Raschi E, Poluzzi E, Puccini A, Cars T, Wettermark B, Diemberger I, Boriani G, De Ponti F. Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. Eur J Clin Pharmacol. 2013 Mar; 69(3):715-20. PMID: 22941408.
      Citations: 3     Fields:    Translation:Humans
    58. Motola D, Piccinni C, Biagi C, Raschi E, Marra A, Marchesini G, Poluzzi E. Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database. Drug Saf. 2012 Apr 01; 35(4):315-23. PMID: 22376166.
      Citations: 11     Fields:    Translation:Humans
    59. Raschi E, De Ponti F. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. Intern Emerg Med. 2012 Apr; 7(2):113-31. PMID: 22161318.
      Citations: 22     Fields:    Translation:Humans
    60. Raschi E, Poluzzi E, Koci A, Boriani G, De Ponti F. QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus. Br J Clin Pharmacol. 2011 Nov; 72(5):839-41. PMID: 21777270.
      Citations: 4     Fields:    Translation:Humans
    61. Raschi E, Boriani G, De Ponti F. Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling. Curr Drug Targets. 2011 Feb; 12(2):263-86. PMID: 21126225.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    62. Boriani G, Diemberger I, Valzania C, Biffi M, Martignani C, Raschi E, Mantovani V, Ziacchi M, Bertini M, De Ponti F, Branzi A. Role of drugs and devices in patients at risk of sudden cardiac death. Fundam Clin Pharmacol. 2010 Oct; 24(5):575-94. PMID: 20608989.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    63. Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. Drug Saf. 2010 Apr 01; 33(4):303-14. PMID: 20297862.
      Citations: 45     Fields:    Translation:Humans
    64. Raschi E, Vasina V, Ursino MG, Boriani G, Martoni A, De Ponti F. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacol Ther. 2010 Feb; 125(2):196-218. PMID: 19874849.
      Citations: 32     Fields:    Translation:HumansAnimals
    65. Raschi E, Ceccarini L, De Ponti F, Recanatini M. hERG-related drug toxicity and models for predicting hERG liability and QT prolongation. Expert Opin Drug Metab Toxicol. 2009 Sep; 5(9):1005-21. PMID: 19572824.
      Citations: 17     Fields:    Translation:HumansAnimals
    66. Poluzzi E, Raschi E, Moretti U, De Ponti F. Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf. 2009 Jun; 18(6):512-8. PMID: 19358226.
      Citations: 43     Fields:    Translation:Humans
    67. Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F. The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res. 2009 Apr; 59(4):221-34. PMID: 19429463.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    68. Raschi E, Poluzzi E, Zuliani C, Muller A, Goossens H, De Ponti F. Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. Br J Clin Pharmacol. 2009 Jan; 67(1):88-98. PMID: 19076158.
      Citations: 4     Fields:    Translation:Humans
    69. Raschi E, Vasina V, Poluzzi E, De Ponti F. The hERG K+ channel: target and antitarget strategies in drug development. Pharmacol Res. 2008 Mar; 57(3):181-95. PMID: 18329284.
      Citations: 38     Fields:    Translation:HumansAnimals